Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes

Area of Science:

• Cardiology
• Genetics
• Stem Cell Biology

Background:

• Genetic mutations in cardiac ion channels and related proteins are linked to heart diseases.
• Traditional in-vitro heterologous expression systems have limitations in replicating the complex cellular environment and pathological remodeling.
• Next-generation sequencing has identified numerous genetic loci, particularly in non-coding DNA, requiring functional validation.

Purpose of the Study:

• To review the current knowledge and applications of induced pluripotent stem cells (iPSCs) in modeling cardiac genetic diseases.
• To highlight how iPSCs overcome the limitations of traditional in-vitro models for studying cardiac genetic disorders.
• To discuss the potential of iPSC-derived cardiomyocytes for understanding long-term mutation effects and guiding personalized pharmacotherapy.

Main Methods:

• Utilizing human embryonic stem cells and reprogramming techniques to generate induced pluripotent stem cells (iPSCs).
• Differentiating iPSCs into cardiomyocytes (CMs) to create patient-specific cellular models.
• Culturing iPSC-derived CMs for extended periods to observe maturation, aging, and electrophysiological remodeling.
• Preserving the patient's complete genetic context within the iPSC model.

Main Results:

• iPSCs provide a more accurate in-vitro model by recapitulating the native intracellular environment and allowing for pathological remodeling.
• Long-term culture of iPSC-derived CMs enables the study of electrophysiological remodeling due to sustained mutation expression.
• The genetic context of iPSCs facilitates the identification of patient-specific responses to pharmacological interventions.
• This approach enhances the understanding of disease mechanisms and aids in developing targeted therapies.

Conclusions:

• Induced pluripotent stem cells (iPSCs) represent a significant advancement in modeling cardiac genetic diseases.
• iPSC technology overcomes critical limitations of heterologous expression systems, offering a more physiologically relevant platform.
• iPSC-derived cardiomyocytes are crucial for investigating long-term disease progression, electrophysiological changes, and personalized medicine in cardiology.